Natural History of Perianal Crohn's Disease After Fecal Diversion

Background:Temporary fecal diversion has been used to allow severe perianal Crohn's disease (CD) to heal. Most data on intestinal reconnection rates precede the biological era with limited patient follow-up after reconnection. We, therefore, sought to evaluate the natural history of perianal CD after fecal diversion. Methods:We identified 49 patients with CD and perianal involvement who underwent fecal diversion between 1991 and 2011 at a tertiary referral care center. Demographics, medication use, onset and extent of disease, and surgical interventions were abstracted. We determined the percentage of patients who were able to restore intestinal continuity and assessed the sustainability of this reversal. Time to intestinal reconnection and subsequent procedures were determined. We also examined temporal trends in the proportion of patients with perianal CD undergoing diversion or management with seton/EUA/fistulotomy between 2000 and 2011. Results:Fifteen of 49 patients (31%) reestablished intestinal continuity during the study follow-up period. Ten of 15 patients (67%) who had reestablished intestinal continuity required an additional procedure to divert the fecal stream. Of the 5 patients who remained reconnected, 3 patients required further procedures to control sepsis. The proportion of patients with CD requiring perianal surgical interventions declined between 2000 and 2011. Conclusions:Severe perianal CD remains a challenging problem. In patients with CD with perianal disease requiring fecal diversion, the likelihood of sustained intestinal continuity remains low, despite greater biological use. However, there has been a temporal decline in the rate of surgical interventions required for perianal CD from 2000 to 2011.

[1]  Y. Panis,et al.  Case Series: Does a Combination of Anti-TNF Antibodies and Transient Ileal Fecal Stream Diversion in Severe Crohn's Colitis With Perianal Fistula Prevent Definitive Stoma? , 2013, The American Journal of Gastroenterology.

[2]  A. Ananthakrishnan,et al.  Impact of Coexistent Celiac Disease on Phenotype and Natural History of Inflammatory Bowel Diseases , 2013, The American Journal of Gastroenterology.

[3]  Amit P. Desai,et al.  Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[4]  W. Sandborn,et al.  Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change , 2011, Gut.

[5]  G. Savoye,et al.  Fistulizing perianal Crohn's disease: Contrast‐enhanced magnetic resonance imaging assessment at 1 year on maintenance anti‐TNF‐alpha therapy , 2011, Inflammatory bowel diseases.

[6]  S. Bell,et al.  Faecal diversion in the management of perianal Crohn’s disease , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[7]  P. Rutgeerts,et al.  Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.

[8]  M. Kreis,et al.  Long-Term Quality of Life in Patients with Crohn’s Disease and Perianal Fistulas: Influence of Fecal Diversion , 2007, Diseases of the colon and rectum.

[9]  M. Kreis,et al.  Risk of Fecal Diversion in Complicated Perianal Crohn’s Disease , 2007, Journal of Gastrointestinal Surgery.

[10]  A. Stromberg,et al.  Perianal Crohn Disease: Predictors of Need for Permanent Diversion , 2005, Annals of surgery.

[11]  P. Rutgeerts,et al.  Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.

[12]  P. Rutgeerts,et al.  Management of perianal Crohn's disease. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[13]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[14]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[15]  W. Cooke,et al.  The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel , 1971, Gut.

[16]  K. Taylor,et al.  Diverting ileostomy in the surgical management of Crohn's disease of the colon. , 1968, American journal of surgery.

[17]  J. Stockman Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2009 .

[18]  I. Kodner,et al.  Techniques and results in the management of anal and perianal Crohn's disease. , 1989, Surgery, gynecology & obstetrics.